Trius prices IPO

Trius Therapeutics Inc. (NASDAQ:TSRX) raised $50 million through the sale of 10 million shares at $5 in an IPO underwritten by Citigroup; Piper Jaffray; Canaccord; and JMP Securities. The price values the company at $117.8 million. On Monday, Trius lowered the price from $12-$14 to $5 while increasing the number of shares to 10 million from 6 million. At the $13 mid-point of the original range and 6 million shares, the company would have raised $78 million and been valued at $216.3 million. Trius was unchanged at $5 on Tuesday. ...